You are here
Atrial Fibrillation (AF) is the most common abnornal heart rhythm that affects almost half a million Australians.
Queensland Cardiovascular Group's cardiologists are further improving the detection and management of the complex condition of heart failure with the use of a new generation of implantable cardiac devices to save lives.
When paired with a remote home monitor, these devices can deliver a sophisticated set of heart failure diagnostics, using a multisensor approach.
5 September, 2019 10:10 AM AEST
Queensland Cardiovascular Group has become the first practice in Australia to use ground-breaking technology to treat patients with heart disease.
Dr John Hayes and Dr Michael Adsett used the cutting-edge cryoballoon catheter device to perform surgery on patients last month.